These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nephrotoxicity in the setting of invasive fungal diseases. Ullmann AJ. Mycoses; 2008; 51 Suppl 1():25-30. PubMed ID: 18471158 [Abstract] [Full Text] [Related]
5. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate. Maharom P, Thamlikitkul V. J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252 [Abstract] [Full Text] [Related]
6. Liposomal amphotericin B for the treatment of severe fungal infection. Michaud D. Dynamics; 2001 Nov; 12(1):17-21. PubMed ID: 11982230 [Abstract] [Full Text] [Related]
19. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. Noel GJ. J Pediatr; 1999 Sep; 135(3):399. PubMed ID: 10523149 [No Abstract] [Full Text] [Related]
20. A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment. Isnard F, Tilleul P, Laporte JP, Chevallier P, Pigneux A, Lafuma A, Mahi L, Deray G. Nephrol Dial Transplant; 2007 Oct; 22(10):3090-1. PubMed ID: 17595189 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]